Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib

• Published in: Redox biology Vol. 36; p. 101611
• Main Authors: Camiolo, Giuseppina, Barbato, Alessandro, Giallongo, Cesarina, Vicario, Nunzio, Romano, Alessandra, Parrinello, Nunziatina L., Parenti, Rosalba, Sandoval, Joaquín Cantón, García-Moreno, Diana, Lazzarino, Giacomo, Avola, Roberto, Palumbo, Giuseppe A., Mulero, Victoriano, Li Volti, Giovanni, Tibullo, Daniele, Di Raimondo, Francesco
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01-09-2020; Elsevier
• Subjects: Iron; Monocyte; Multiple myeloma; Research Paper; Zebrafish; Zebrafish; Iron; Monocyte; Multiple myeloma
• ISSN: 2213-2317; 2213-2317
• DOI: 10.1016/j.redox.2020.101611

Iron plays a major role in multiple processes involved in cell homeostasis such as metabolism, respiration and DNA synthesis. Cancer cells exhibit pronounced iron retention as compared to healthy counterpart. This phenomenon also occurs in multiple myeloma (MM), a hematological malignancy characterized by terminally differentiated plasma cells (PCs), in which serum ferritin levels have been reported as a negative prognostic marker. The aim of current study is to evaluate the potential role of iron metabolism in promoting drug resistance in myeloma cancer cells with particular regard to the interactions between PCs and tumor-associated macrophages (TAMs) as a source of iron. Our data showed that myeloma cell lines are able to intake and accumulate iron and thus, increasing their scavenger antioxidant-related genes and mitochondrial mass. We further demonstrated that PCs pre-treated with ferric ammonium citrate (FAC) decreased bortezomib (BTZ)-induced apoptosis in vitro and successfully engrafted in zebrafish larvae treated with BTZ. Treating human macrophages with FAC, we observed a switch toward a M2-like phenotype associated with an increased expression of anti-inflammatory markers such as ARG1, suggesting the establishment of an iron-mediated immune suppressive tumor microenvironment favouring myeloma growth. Using mfap4:tomato mutant zebrafish larvae, we further confirmed the increase of PCs-monocytes interactions after FAC treatment which favour BTZ-resistance. Taken together our data support the hypothesis that targeting iron trafficking in myeloma microenvironment may represent a promising strategy to counteract a tumor-supporting milieu and drug resistance.
[Display omitted]
•Myeloma cell lines uptake iron and increase oxidative-redox related genes.•Iron increases mitochondrial biogenesis and fitness in myeloma cell lines.•Iron promotes bortezomib resistance in myeloma cell lines.•Zebrafish xenografts of myeloma cell lines exposed to iron exhibit bortezomib resistance.•Iron exposition promotes monocytes-plasma cells interactions and immunomodulation.